Results 31 to 40 of about 63,437 (146)

Diagnostic Use of Testing for Novel Murine Autoantibodies for Sjögren Disease in the Rheumatology Outpatient Setting

Arthritis Care &Research, EarlyView.
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr, Michael D. George, Vatinee Y. Bunya, Nora Sandorfi, Mina Massaro‐Giordano, Frederick B. Vivino   +5 more
wiley   +1 more source

Institutionalization risk and costs associated with agitation in Alzheimer's disease

Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2019
Introduction Agitation in individuals with Alzheimer's disease (AD) may predict institutionalization. This study assessed the incremental risk and costs associated with agitation in individuals with AD.
Martin Cloutier, Marjolaine Gauthier‐Loiselle, Patrick Gagnon‐Sanschagrin, Annie Guerin, Ann Hartry, Ross A. Baker, Ruth Duffy, Keva Gwin, Myrlene Sanon Aigbogun, Alzheimer's Disease Neuroimaging Initiative   +9 more
doaj   +1 more source

Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis

BMC Neurology, 2019
Background Although patients with dementia frequently experience neuropsychological symptoms (NPS) such as agitation, which profoundly impacts patients, caregivers, and the healthcare system, few studies have evaluated the associated burden of agitation ...
Myrlene Sanon Aigbogun, Robert Stellhorn, Ann Hartry, Ross A. Baker, Howard Fillit   +4 more
doaj   +1 more source

Electroactive Metal–Organic Frameworks for Electrocatalysis

Advanced Functional Materials, EarlyView.
Electrocatalysis is crucial in sustainable energy conversion as it enables efficient chemical transformations. The review discusses how metal–organic frameworks can revolutionize this field by offering tailorable structures and active site tunability, enabling efficient and selective electrocatalytic processes.
Irena Senkovska, Yutong Luo, Ruyan Zhao, Jianjun Zhang, Mingchao Wang, Xinliang Feng, Eike Brunner, Stefan Kaskel   +7 more
wiley   +1 more source

Development and Use of a Residence Time Distribution (RTD) Model Control Strategy for a Continuous Manufacturing Drug Product Pharmaceutical Process

Pharmaceutics, 2022
Residence-time-distribution (RTD)-based models are key to understanding the mixing dynamics of continuous manufacturing systems. Such models can allow for material traceability throughout the process and can provide the ability for removal of non ...
Samantha Hurley, Anthony Tantuccio, Manuel Sebastian Escotet-Espinoza, Matthew Flamm, Matthew Metzger   +4 more
doaj   +1 more source

Outstanding Contributions to Aerosol Pulmonary Drug Delivery

KONA Powder and Particle Journal
Dose accuracy and precision for pulmonary drug delivery have been core elements of therapy for asthma for 70 years. As the technology has developed, its application has spread to various diseases.
Anthony J. Hickey, Erik S. Pena, Sara E. Maloney Norcross   +2 more
doaj   +1 more source

Time dependence of magnetic moment of strontium-ferrite powder measured with a biaxial vibrating sample magnetometer (VSM)

AIP Advances, 2021
The magnetic hysteresis and viscosity of SrO(Fe2O3)6/PA-12 filaments with 5wt% and 26wt% was determined with a biaxial VSM. The hysteresis curves indicate that manufactured samples have a flow induced anisotropy with an easy plane perpendicular to the ...
Tanjina Nasreen Ahmed, Maria Camila Belduque, D. C. Binod, Jitendra S. Tate, Wilhelmus J. Geerts   +4 more
doaj   +1 more source

Structure and Magnetism of Iron-Substituted Nickel Hydroxide Nanosheets

Magnetochemistry, 2023
Nanosheets composed of stacked atomic layers exhibit unique magnetic, electrical, and electrochemical properties. Here, we report the effect of iron substitution on the structure and magnetism of nickel hydroxide, Ni(OH)2, nanosheets.
Samuel W. Kimmel, Barry D. Koehne, Ben Gibson, Wilhelmus J. Geerts, Nikoleta Theodoropoulou, Christopher P. Rhodes   +5 more
doaj   +1 more source

Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4

Kidney International Reports, 2017
In the randomized placebo-controlled Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes (TEMPO) 3:4 trial, tolvaptan slowed kidney growth and renal function decline in subjects with autosomal ...
Olivier Devuyst, Arlene B. Chapman, Susan E. Shoaf, Frank S. Czerwiec, Jaime D. Blais   +4 more
doaj   +1 more source

Polycystic Kidney Disease–Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative StudyPlain-Language Summary

Kidney Medicine, 2022
Rationale & Objective: Little is known about symptoms and disease impacts in adolescents with autosomal dominant polycystic kidney disease (ADPKD).
Dorothee Oberdhan, Franz Schaefer, Jason C. Cole, Andrew C. Palsgrove, Ann Dandurand, Lisa Guay-Woodford   +5 more
doaj   +1 more source